MedPath

Comparing Two Different Surgical Techniques for Breast Reconstruction

Phase 3
Withdrawn
Conditions
Breast Reconstruction
Interventions
Procedure: Prepectoral Prosthetic Breast Reconstruction
Procedure: Subpectoral Prosthetic Breast Reconstruction
Registration Number
NCT04716959
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to compare two standard techniques for breast reconstruction-the prepectoral technique and the subpectoral technique. Again, the prepectoral technique involves putting a tissue expander on top of the pectoralis muscle, while the subpectoral technique involves putting a tissue expander under the pectoralis muscle.

The standard approach used at MSK is the subpectoral technique. This study will help researchers find out whether the subpectoral approach is better, the same as, or worse than the prepectoral approach. To decide which approach is better, the researchers will look at which technique causes fewer complications after surgery (for example, infection or the need for a second surgery). Researchers are also interested in seeing which approach causes less pain and use of pain medication after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Women aged 21-60 years
  • Planning to undergo immediate two stage prosthetic breast reconstruction with TE placement as the first stage.
  • Planning to undergo unilateral or bilateral mastectomy.
  • Planning to undergo nipple- or skin-sparing mastectomy.
  • Mastectomy weight less than 800 grams.
  • Adequate mastectomy skin perfusion or patients with adequate perfusion but nonviable mastectomy skin that can be excised (≤ 4 cm) at the defect margins with otherwise adequate perfusion.
Exclusion Criteria
  • Receipt of neoadjuvant chemotherapy for locally advanced breast cancer.
  • Presence of preoperative axillary lymph node metastasis.
  • Presence of intraoperative sentinel node positivity.
  • History of radiotherapy.
  • Current smoker.
  • Planning to undergo direct-to-implant reconstruction.
  • BMI >35.
  • Prior sternotomy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Prepectoral Prosthetic Breast ReconstructionPrepectoral Prosthetic Breast Reconstruction-
Subpectoral Prosthetic Breast ReconstructionSubpectoral Prosthetic Breast Reconstruction-
Primary Outcome Measures
NameTimeMethod
major perioperative complications90 days

90-day major complications for tissue expanders (i.e., infection, explantation, and reoperation for mastectomy flap necrosis):

* Infection: any event requiring restart of antibiotics (oral or intravenous) following completion of initial perioperative antibiotics or an admission to the hospital for cellulitis.

* Explantation: need for tissue expander removal for any cause.

* Reoperation: skin excision performed in either the clinic or the main operating room for mastectomy skin flap necrosis.

Secondary Outcome Measures
NameTimeMethod
minor complications90 days

Minor complication for tissue expanders is defined as: Seroma: clinically significant non-infected fluid collection requiring either needle aspiration or drain replacement

Trial Locations

Locations (7)

Memorial Sloan Kettering Bergen (Consent and Followup )

🇺🇸

Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Consent and Followup)

🇺🇸

Commack, New York, United States

Memorial Sloan Kettering Westchester (Consent and Followup)

🇺🇸

Harrison, New York, United States

Memorial Sloan Kettering Monmouth (Consent and Followup)

🇺🇸

Middletown, New Jersey, United States

Memorial Sloan Kettering BaskingRidge (Consent and Followup)

🇺🇸

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Nassau (Consent and Followup)

🇺🇸

Rockville Centre, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath